Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction chemotherapy followed by radiotherapy with concomitant cetuximab in head and neck squamous cell carcinoma
2007-004099-38Phase 2Completed
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Aug 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in head and neck squamous cell carcinoma (HNSCC) and Upper Respiratory Tract Neoplasm, sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoint: Complete and partial response rate. Started Aug 2007; status: completed.
02
Drugs
cetuximab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)Upper Respiratory Tract Neoplasm
Beyond the preview
Go deeper on 2007-004099-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004099-38.